News

Featured Articles

Cristalia products with Nemera’s reusable pen injector commercialized in Brazil.

Cristalia’s human growth hormone will be administered with CRISPEN®. Approved by ANVISA1, CRISPEN® is part of Nemera’s state-of-the-art pen injector platform PENDURA AD.

2021 Events

International Women’s Day 2021

06/04/2021

Celebrating our leaders, not with a rose, but with a voice. An equal world is an empowered world. At Nemera, each individual is unique with a unique story and we...

featured image for new board member news

2020

Nemera announces the appointment of Véronique Kodjo as non-Executive member of the board

27/05/2021

Nemera, world leader in design, development and manufacturing of drug device combination solutions for the pharmaceutical, biotechnology and generic industries, today announced the appointment of senior leader Véronique Kodjo as...

2021

Nemera is committed to Gender Equality

09/03/2021

The Gender Equality Index at Nemera Declared the “most important cause of the next five years” by the President of the French Republic, Gender Equality is at the heart of...

2020 COVID

Nemera’s safety measures during the COVID-19 pandemic

05/06/2021

Nemera’s safety measures during the COVID-19 pandemic As people and companies make their way through the COVID-19 pandemic, sharing best practices around crisis management has become the need of ...

2020

Nemera’s commitment to patients and employees remains unwavered amid the COVID-19 pandemic

05/06/2021

Nemera’s commitment to patients and employees remains unwavered amid the COVID-19 pandemic The last few weeks have been truly challenging for all of us with the global spread of ...

2020 Events

Nemera is exhibiting at Pharmapack 2020!

05/06/2021

Can’t wait to meet YOU at Pharmapack 2020, on February 5-6, in Paris! Nemera will be one of the over 410 international exhibiting companies at the next Pharmapack 2020, which...